Skip to main content

KU 272 Pill - white round, 9mm

Pill with imprint KU 272 is White, Round and has been identified as Oxybutynin Chloride Extended-Release 15 mg. It is supplied by Chartwell RX, LLC.

Oxybutynin is used in the treatment of Overactive Bladder; Neurogenic Detrusor Overactivity; Dysuria; Urinary Incontinence; Urinary Frequency and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 272

Oxybutynin chloride extended-release 15 mg KU 272
Oxybutynin chloride extended-release 15 mg KU 272 Front
Oxybutynin chloride extended-release 15 mg KU 272 Back
Oxybutynin chloride extended-release 15 mg KU 272
Oxybutynin chloride extended-release 15 mg KU 272

Oxybutynin Chloride Extended-Release

Imprint
KU 272
Strength
15 mg
Color
White
Size
9.00 mm
Shape
Round (biconvex)
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Chartwell RX, LLC
Inactive Ingredients
lactose anhydrous, lactose monohydrate, mannitol, dextrose, anhydrous, tartaric acid, silicon dioxide, magnesium stearate, cellulose acetate, polyethylene glycol 400, titanium dioxide, ferrosoferric oxide, propylene glycol, hypromellose 2208 (100 mPa.s), triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
62175-0272 Kremers Urban Pharmaceuticals Inc.
42291-0635 AvKare, Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer